| Document Date: 2009-10-14 17:39:38
Open Document File Size: 966,70 KBShare Result on Facebook
City Gadolinium / / Currency CAD / / Event Product Issues / / Facility Laboratory Test Interactions / Laboratory Test Interactions Transient / / IndustryTerm colorless aqueous solution / magnetic resonance imaging / imaging / non-contrast enhanced magnetic resonance imaging / nuclear medicine imaging / / MedicalCondition hemolytic anemias / neoplasms / allergies / hepatic metabolic disorders / von Willebrands' disease / allergic respiratory diseases / cysts / siCkle cell anemia / heart disease / mature post-operative scars / hepato-renal syndrome / metastatic disease / systemic fibrosis / mg/mL NEPHROGENIC SYSTEMIC FIBROSIS WARNING / renal disease / hypersensitivity / Wilsons' disease / metabolic disorders / end-stage renal disease / renal dysfunction / nephrogenic systemic fibrosis / Dissociation / WARNINGS Nephrogenic Systemic Fibrosis / asthma / hemoglobinopathies / necrosis / tumors / disease / chronic severe renal insufficiency / Carcinogenesis / cardiac arrhythmias / allergic disorders / abscesses / seizure / Dubin Johnson syndrome / acute renal insufficiency / renal insufficiency / diseases / coronary artery disease / Cell Disease / non-tumor CNS disease / anemia / / MedicalTreatment emergency treatment / hemodialysis / dialysis / / Organization National Science Foundation / MUL TIHANCE administration / MULTI administration / / Position physician / PRECAUTIONS General / / Product Omniscan / Upon injection / Palm Pre Plus Smartphone / MULTIHANCE / etoposide / taxol / renal function / / Technology tomography / transplantation / MRI / Pharmacokinetics / magnetic resonance imaging / radio frequency / Pharmacodynamics / dialysis / CAD / /
SocialTag |
MultihanceQ! (gadobenate dimeglumine) injection, 529 mg/mL NEPHROGENIC SYSTEMIC FIBROSIS